Parallax Volatility Advisers’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-20,000
Closed -$9.34M 1651
2025
Q4
$9.34M Hold
20,000
0.02% 488
2025
Q3
$8.52M Hold
20,000
0.01% 516
2025
Q2
$7.66M Sell
20,000
-5,000
-20% -$1.8M 0.02% 509
2025
Q1
$8.64M Buy
+25,000
New +$8.04M 0.02% 483
2024
Q2
Sell
-1,800
Closed -$600K 2118
2024
Q1
$600K Sell
1,800
-10,500
-85% -$3.21M ﹤0.01% 1355
2023
Q4
$3.33M Buy
12,300
+10,800
+720% +$2.67M 0.01% 984
2023
Q3
$369K Buy
1,500
+900
+150% +$246K ﹤0.01% 1680
2023
Q2
$182K Sell
600
-6,300
-91% -$1.75M ﹤0.01% 1902
2023
Q1
$1.82M Sell
6,900
-39,100
-85% -$9.93M ﹤0.01% 1262
2022
Q4
$11M Buy
46,000
+5,700
+14% +$1.28M 0.02% 740
2022
Q3
$7.41M Buy
40,300
+9,200
+30% +$1.83M 0.01% 868
2022
Q2
$5.23M Sell
31,100
-9,300
-23% -$2M 0.01% 959
2022
Q1
$10.1M Buy
40,400
+32,100
+387% +$8.06M 0.01% 741
2021
Q4
$2.13M Buy
8,300
+6,400
+337% +$1.57M ﹤0.01% 1065
2021
Q3
$461K Buy
+1,900
New +$465K ﹤0.01% 1528
2021
Q1
Sell
-269,400
Closed -$44.3M 1484
2020
Q4
$44.3M Sell
269,400
-70,900
-21% -$10.4M 0.04% 320
2020
Q3
$42.4M Buy
340,300
+115,600
+51% +$14.3M 0.03% 452
2020
Q2
$21.8M Buy
224,700
+26,800
+14% +$2.79M 0.03% 495
2020
Q1
$17.8M Buy
197,900
+153,000
+341% +$19.8M 0.02% 434
2019
Q4
$6.64M Buy
+44,900
New +$6.03M 0.01% 794
2019
Q2
Sell
-1,500
Closed -$195K 3036
2019
Q1
$195K Sell
1,500
-4,600
-75% -$618K ﹤0.01% 1901
2018
Q4
$758K Buy
+6,100
New +$819K ﹤0.01% 1398
2018
Q1
Sell
-550,000
Closed -$48.3M 3063
2017
Q4
$48.3M Buy
550,000
+250,000
+83% +$20.1M 0.07% 136
2017
Q3
$23.9M Hold
300,000
0.04% 227
2017
Q2
$26.2M Sell
300,000
-502,300
-63% -$42.5M 0.05% 215
2017
Q1
$71.4M Buy
802,300
+122,400
+18% +$10.2M 0.15% 89
2016
Q4
$50.3M Buy
679,900
+29,900
+5% +$2.24M 0.1% 147
2016
Q3
$49.2M Buy
650,000
+250,000
+63% +$19.1M 0.09% 140
2016
Q2
$30.8M Sell
400,000
-1,200
-0.3% -$94.7K 0.06% 214
2016
Q1
$31.3M Buy
+401,200
New +$28M 0.07% 180
2015
Q4
Sell
-200
Closed -$15K 3284
2015
Q3
$15K Sell
200
-49,800
-100% -$4.41M ﹤0.01% 2495
2015
Q2
$4.54M Sell
50,000
-41,200
-45% -$3.3M 0.01% 746
2015
Q1
$6.86M Buy
91,200
+35,900
+65% +$2.58M 0.02% 599
2014
Q4
$4.06M Sell
55,300
-75,600
-58% -$5.31M 0.01% 770
2014
Q3
$9.23M Buy
130,900
+128,400
+5,136% +$8.49M 0.03% 484
2014
Q2
$142K Sell
2,500
-1,900
-43% -$100K ﹤0.01% 2240
2014
Q1
$231K Buy
4,400
+2,400
+120% +$119K ﹤0.01% 1382
2013
Q4
$97K Sell
2,000
-9,300
-82% -$430K ﹤0.01% 1848
2013
Q3
$484K Sell
11,300
-2,500
-18% -$97.7K ﹤0.01% 836
2013
Q2
$499K Buy
+13,800
New +$534K ﹤0.01% 832

Other funds holding HCA

Parallax Volatility Advisers's HCA Position: Q2 2025 in Review

Parallax Volatility Advisers sold out of HCA Healthcare (HCA) in Q2 2025, closing a stake of 2 shares — an estimated $721 sold.

Parallax Volatility Advisers first reported a position in HCA in Q2 2013 and held it in 28 quarters. The position peaked at $8.99M in Q2 2020. 1,248 funds tracked by Wall St. Rank hold HCA as of Q2 2025.

  • Parallax Volatility Advisers reported no remaining HCA Healthcare position as of Q2 2025 after selling out during the quarter.
  • Parallax Volatility Advisers sold 2 HCA Healthcare shares in Q2 2025, an estimated $721.
  • Parallax Volatility Advisers first reported a position in HCA Healthcare in Q2 2013 and held it in 28 quarters.
  • Parallax Volatility Advisers's HCA Healthcare position peaked at $8.99M in Q2 2020.
  • 1,248 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2025.

Based on Parallax Volatility Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.